TTUHSC School of Pharmacy
HomeSOPPharmacy PracticeDrug Information CenterForumForum

Pharmacy Practice

Drug Information Center – Forum
Volume 1, Issue 1

Thursday, September 21, 2000


  • David Wofford
  • Zachary House
  • Phillip Blake
  • Carlos Alvaraz
  • Naaman Garza
  • Michelle Morris


New Drug Approvals

  • Depakote ER – 08-04-00
    • Divalproex sodium- extended release tablet.
    • Approved for prophylaxis of migraine headaches in adults
    • Manufactured by Abbott laboratories.
  • Concerta – 08-01-00
    • Methylphenidate sodium-extended release tablet
    • Approved for treatment of attention deficit disorder
    • Manufactured by Alza Corporation
  • Children's Motrin Cold – 08-01-00
    • Ibuprofen and pseudoephedrine HCl-oral suspension
    • Approved for temporary relief of nasal and sinus congestion, minor aches and pains, fever, stuffy nose, headache and sore throat.
    • Manufactured by McNeil Consumer Healthcare

New Drug Indications

  • Fluoxetine – 08-01-00
    • First drug approved for PMS
    • Indications : depression, obsessive compulsive disorder, bulimia. Recently approved for treatment of premenstrual dysphoric disorder
    • Manufactured by Eli Lilly & Company

Drug Recalls


  • Cortef Oral Suspension
    • Class II
    • Pharmacia Corporation
    • May not be effective for the treatment of congenital adrenal hyperplasia


  • Estratab 2.5mg tablet
    • Class III
    • Solvay Pharmaceuticals
    • Tablets did not meet friability specification
  • Pannaz tablet
    • Class III
    • Anabolic Laboratories, Inc.
    • Lack of complete manufacturing process validation

Pharmacy Literature Review

Closing the Loop-Implementing Quality Improvement Processes and Advances in Technology to Decrease Medication Errors

"Implementation of technology is necessary to improve the safety of medications. Use of radio frequency handheld devices, computerized order entry systems and bar coded medications coupled with an active QI program to assess medication safety is required to manage medication safety. As new technology and progress are implemented to St. Peter's Hospital, the Medication Safety Team as well as the other components of the MUE program will assess new issues as they arise and implement corrective measures."
Thomas P. Lombardi, Pharm.D, FASHP Medscape Pharmacists, 2000

If you would like to read this article visit and select the Specialty Spotlight under pharmacists. Registration is required but free of charge.

This Issue's Review Article

Coagulation Products and their Uses

AM .J. Health-Systems Pharm. 2000; 57: 1403-20

Shord and Lindley present an excellent review of coagulation products including indications, pharmacokinetics, and therapeutic guidelines. A review of coagulation is presented and available coagulation products are discussed. Click on the hyper-linked title above for the complete article.

H. Glenn Anderson, Jr Pharm.D.
Ann L. McIlvain Pharm.D
Texas Tech University HSC
School of Pharmacy
Drug Information Center